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Summary
 
Telomerase, which maintains the ends of chromosomes,
consists of two core components, the telomerase reverse
transcriptase (
 
TERT
 
)  and the telomerase RNA (
 
TERC
 
).
Haploinsufficiency for 
 
TERC
 
 or 
 
TERT
 
 leads to progressive
telomere shortening and autosomal dominant dyskeratosis
congenita (DC). The clinical manifestations of autosomal
dominant DC are thought to occur when telomeres become
critically short, but the rate of telomere shortening in this
condition is unknown. Here, we investigated the conse-
quences of 
 
de novo TERT
 
 gene deletions in a large cohort
of individuals with 5p– syndrome. The study group included
41 individuals in which the chromosome deletion resulted in
loss of one copy of the 
 
TERT
 
 gene at 5p15.33. Telomere
length in peripheral blood cells from these individuals,
although within the normal range, was on average shorter
than in normal controls. The shortening was more significant
in older individuals suggesting an accelerated age-dependent
shortening. In contrast, individuals with autosomal dominant
DC due to an inherited 
 
TERC
 
 gene deletion had very short
telomeres, and the telomeres were equally short regardless
of the age. Although some individuals with 5p– syndrome
showed clinical features that were reminiscent of auto-
somal dominant DC, these features did not correlate with
telomere length, suggesting that these were not caused
by critically short telomeres. We conclude that a 
 
TERT
 
gene deletion leads to slightly shorter telomeres within
one generation. However, our results suggest that several
generations of 
 
TERT
 
 haploinsufficiency are needed to pro-
duce the very short telomeres seen in patients with DC.
Key words: 5p– syndrome; dyskeratosis congenita; haplo-
insufficiency; telomerase reverse transcriptase; telomerase
RNA component, telomere.
 
Introduction
 
Telomerase is a ribonucleoprotein complex that maintains the
ends of chromosomes. It consists of two core components, the
telomerase reverse transcriptase (
 
TERT
 
) and the telomerase RNA
(
 
TERC
 
), that serves as a template for the synthesis of telomeric
DNA repeats at chromosome ends (Greider & Blackburn, 1987).
Loss of telomerase activity leads to progressive telomere short-
ening and loss of telomere integrity (Blackburn, 2001). When
telomeres become critically short, cell cycle arrest or cell death
occurs (Kim 
 
et al
 
., 1994). Haploinsufficiency for 
 
TERC
 
 causes the
autosomal dominant variant of dyskeratosis congenita (DC)
(Vulliamy 
 
et al
 
., 2001).
DC is a rare inherited bone marrow failure syndrome. In addi-
tion to progressive bone marrow failure, clinical features include
nail dystrophy, abnormal skin pigmentation and mucosal
leukoplakia (Knight 
 
et al
 
., 1998). Patients with DC have very
short telomeres (Vulliamy 
 
et al
 
., 2001), suggesting that excessive
premature telomere shortening is responsible for the develop-
ment of the disease in these individuals (for review, see Mason
 
et al
 
., 2005). More recently, 
 
TERT
 
 gene mutations have been
identified in rare individuals with autosomal dominant DC and
in sporadic cases of bone marrow failure (Armanios 
 
et al
 
., 2005;
Vulliamy 
 
et al
 
., 2005; Yamaguchi 
 
et al
 
., 2005; Liang 
 
et al
 
., 2006;
Vulliamy & Dokal, 2006; Xin 
 
et al
 
., 2007). In autosomal domi-
nant DC, the age of onset is earlier and the disease is more severe
in later generations who carry the pathogenic mutation, a
phenomenon known as anticipation (Vulliamy 
 
et al
 
., 2001;
Mason, 2003). Disease anticipation in autosomal dominant DC
is thought to be due to the inheritance of increasingly short
telomeres in subsequent generations (Vulliamy 
 
et al
 
., 2004;
Goldman 
 
et al
 
., 2005). The rate of telomere shortening has been
extensively studied in telomerase-deficient mice. Mice with no
telomerase function, either because of a 
 
Terc
 
 gene deletion
(
 
Terc
 
 RNA–/– mice) or due to a null mutation in the 
 
Tert
 
 gene
(
 
Tert–
 
/– mice), showed no obvious phenotype in the early gen-
erations of inbreeding despite progressive telomere shortening.
Three to six generations of inbreeding were necessary to produce
telomeres sufficiently short to cause a ‘short telomere pheno-
type’ (Blasco 
 
et al
 
., 1997; Herrera 
 
et al
 
., 1999; Liu 
 
et al
 
., 2000;
Niida 
 
et al
 
., 2000). The rate of telomere shortening in human
haploinsufficiency for 
 
TERC
 
 or 
 
TERT
 
 is not known. Similarly, the
number of generations that of haploinsufficiency and increas-
ingly short telomeres has to be inherited before telomeres
become critically short is unknown.
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To explore the impact of 
 
de novo TERT
 
 haploinsufficiency on
telomere shortening, we studied a large number of individuals
with 5p– syndrome having a 
 
TERT
 
 gene deletion. The 5p–
syndrome, also know as Cri du Chat syndrome, or monosomy
5p, is one of the most frequent autosomal deletion syndromes.
The deletions involve the short arm of chromosome 5 and
usually encompass 
 
TERT
 
 gene located at 5p15.33 (Meyerson
 
et al
 
., 1997; Zhang 
 
et al
 
., 2003). This syndrome has several
phenotypic components including the characteristic cry that gives
the syndrome its name, facial dysmorphology, speech delay and
mental retardation (Mainardi 
 
et al
 
., 2006). Clinical manifesta-
tions vary with the size and location of the chromosomal dele-
tion (Overhauser 
 
et al
 
., 1994; Gersh 
 
et al
 
., 1995; Kim & Wu,
1997; Mainardi 
 
et al
 
., 2006). The deletion in individuals with
5p– syndrome is either a 
 
de novo
 
 event or is inherited from a
parent with a balanced translocation (Mainardi 
 
et al
 
., 2006).
Consequently, individuals with 5p– syndrome whose deletion
includes the 
 
TERT
 
 gene are the first generation to be haplo-
insufficient for 
 
TERT
 
 (
 
de novo
 
 
 
TERT
 
 gene deletion). Classical
features of DC have not been associated with the syndrome;
however, only few individuals have been followed into adult-
hood and no hematological assessments have been performed.
We were, therefore, interested in the degree of telomere
shortening in individuals with 5p– syndrome due to the phe-
nomenon of anticipation in autosomal dominant DC and in
whether haploinsufficiency for 
 
TERT
 
 may contribute to the clin-
ical spectrum of the 5p– syndrome. Our investigations demon-
strate that the majority of individuals with 5p– had only one
copy of the 
 
TERT
 
 gene. Telomeres measured in peripheral blood
cells from individuals with 5p– syndrome and a 
 
TERT
 
 gene dele-
tion, although significantly shorter than age-matched controls,
remained within normal levels and did not approach the severely
shortened telomeres seen in patients with autosomal dominant
DC. We conclude that a 
 
de novo TERT
 
 gene deletion, although
associated with shorter telomeres, does not lead to critically
short telomeres within one generation and that clinical mani-
festations of the 5p– syndrome are unlikely to be caused by pre-
mature shortening of telomeres.
 
Results
 
Individuals with 5p– syndrome have clinical 
manifestations consistent with premature aging
 
Fifty-one families with at least one family member affected with
the 5p– syndrome participated in our study. Fifty-two particip-
ants had 5p– syndrome; 79 were unaffected family members.
The median age of participants with 5p– syndrome was 9 years
old (range, 1–42 years), and that of unaffected family members
(parents and siblings) was 41 years old (range, 2–70 years). All
individuals with 5p– syndrome showed typical clinical features
(Mainardi 
 
et al
 
., 2006) including, on review, the cat-like cry and
specific alteration of the voice, facial anomalies (i.e. epicanthal
folds, microretrognathia), and psychomotor and mental retar-
dation. In addition to the classical features of 5p– syndrome,
ridging of the fingernails was noted in 14 individuals with 5p–
syndrome and early hair graying in 10 individuals. Both ridging
of the fingernails and early hair graying are early cutaneous
manifestations characteristic of DC. The youngest participant
with ridged fingernails was 2 years old and the youngest with
early graying of the hair was 12 years old. Telomere lengths in
individuals with 5p– syndrome having ridged finger/toe nails
were not significantly different from the individuals without
ridged nails (
 
P = 
 
0.92). Similarly, there was no statistically significant
difference of telomere length between individuals with 5p– syn-
drome having early hair graying/loss and without this feature
(
 
P = 
 
0.80). Leukoplakia, another characteristic manifestation of
DC, was not seen in any of the participants with 5p– syndrome.
 
Deletion of one copy of 
 
TERT
 
 in individuals with 5p– 
syndrome
 
We determined the copy number of the 
 
TERT
 
 gene by quanti-
tative polymerase chain reaction (Q-PCR). While the 79 un-
affected family members had an average copy number of 
 
TERT
 
of 1.89 
 
±
 
 0.26, the 42 individuals with 5p– syndrome had an
average of 1.00 
 
±
 
 0.14 (
 
P = 
 
4.5 
 
×
 
 10
 
–39
 
, Fig. 1). The result sug-
gests that there is a concomitant deletion of 
 
TERT
 
 in the majority
of participants having deletion of 5p. We identified three indi-
viduals with 5p– having two copies of the 
 
TERT
 
 gene (Fig. 1,
open circles), indicating an interstitial deletion sparing the 
 
TERT
 
locus was responsible for the syndrome, as confirmed by fluo-
rescence 
 
in situ
 
  hybridization (FISH) analysis. Representative
examples are shown in Fig. 2. Figure 2A,B shows FISH analysis
of activated lymphocytes from an unaffected family member
with two copies of 5p and two copies of 5q, labeled by green
and pink, respectively. The two copies of the 
 
TERT
 
 gene hybrid-
izing to the respective probe are shown in red (Fig.  2B).
Figure 2C,D shows an example of an individual with 5p– whose
Fig. 1 Copy number of TERT in individuals with 5p– syndrome and family 
members. Gene copy number was determined by quantitative polymerase 
chain reaction (PCR). The majority of 5p– individuals have only one copy of 
the TERT gene ( , n = 41), whereas there are two copies of TERT in family 
members (×, n = 70). In three individuals with 5p– syndrome ( , n = 3), two 
copies of TERT were identified, suggesting that 5p– was due to interstitial 
deletion on 5p–. 
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deletion of chromosome 5p includes the 
 
TERT
 
 gene. Figure 2E,F
illustrates an example of a balanced translocation including
chromosome 5p in an unaffected parent who has a child with
5p– due to the inheritance of an unbalanced translocation. In
the parent, 5p and 5q are found on two different chromosomes,
similarly, the 
 
TERT
 
 gene is found on two different chromosomes.
Figure 2G,H shows FISH analysis of metaphases of lymphocytes
from an individual with 5p– due to an interstitial deletion with
two hybridization signals for the 
 
TERT
 
 gene, but on one chro-
mosome 5 the hybridization signal for 5p is missing.
In humans after birth 
 
TERT
 
 has been shown to be expressed
in germ cells, stem cells and their immediate progeny, and in
activated lymphocytes and monocytes (Kim 
 
et al
 
., 1994; Feng
 
et al
 
., 1995; Nakamura 
 
et al
 
., 1997; Masutomi 
 
et al
 
., 2003). To
investigate whether haploinsufficiency for the 
 
TERT
 
  gene is
associated with a reduced level of 
 
TERT
 
 mRNA and reduced
levels of telomerase activity, we measured the levels of 
 
TERT
 
 mRNA
and telomerase activity in activated T cells after incubations with
anti-CD3 and anti-CD28 antibodies. The levels of 
 
TERT
 
 mRNA
as measured by Q-PCR and of telomerase activity as determined
by Q-PCR (Kim & Wu, 1997; Uehara, 2006) were highly variable
and not significantly different in individuals with 5p– syndrome
vs. normal controls (see Supplementary Fig. S1A). However, our
finding of accelerated telomere shortening (see below) indirectly
indicates that functional haploinsufficiency is likely to operate
in individuals with 5p– syndrome.
 
Shortened telomeres in individuals with 5p– syndrome
 
It has been well established that telomere length shortens
with age in somatic cells (Harley 
 
et al
 
., 1990; Hastie et al., 1990;
Nordfjall et al., 2005). Telomere lengths were determined from
105 healthy individuals aged from 3 to 94 years. The 5th, 10th,
25th, 50th, 75th and 90th percentiles of the age-dependent
distribution of telomere lengths are shown in Fig. 3. We have
used the general linear model (GLM) procedure to analyze the
association between telomere length and TERT gene deletion,
age, gender and race. Consistent with previous reports, we
found a negative association between telomere lengths and age
(P < 0.001). In contrast, gender and race were not significant
predictors of telomere lengths (P = 0.993 and 0.239, respec-
tively). Although at first glance telomere lengths in individuals
with 5p– seemed not to differ much from normal controls by
either flow cytometry FISH or Southern blot analysis (Fig. 3A,B),
statistical analysis revealed a significant association between
telomere length and the copy number of TERT (P = 0.0066).
Furthermore, age-dependent telomere shortening in individuals
with 5p– syndrome and a concomitant TERT gene deletion seemed
to be accelerated compared to normal controls (r = –0.09,
P = 0.0046 vs. r = –0.07, P < 0.001), but this did not reach sta-
tistical significance due to the low number of older individuals
with 5p– syndrome and the wide distribution of telomere
lengths [95% confidence interval (CI): –0.15 to –0.03 vs. –0.09
to –0.05]. However, when compared to telomere lengths from
individuals with autosomal dominant DC due to a TERC gene
Fig. 2 Fluorescent in situ hybridization (FISH) of metaphase chromosomes 
from individuals with 5p– syndrome and their family members. Representative 
FISH analysis of lymphocyte metaphase from a normal control (A, B), an 
individual with 5p– syndrome and a TERT deletion (C, D), a parent with 
balanced translocation (E, F), and an individual with 5p– syndrome having 
an interstitial deletion but two copies of TERT (G, H) are shown. The TERT, 
5p15.2 and 5q31 markers were labeled by red, green and pink, respectively. 
Two copies of 5p (A, B), 5q (A) and the TERT gene (B) are found in the normal 
individual. Metaphase chromosomes from the individual with 5p– syndrome 
and with a terminal deletion include one copy of 5p and one copy of TERT 
(C, D). A parent of an individual with 5p syndrome shows a balanced 
translocation of 5p, with one of the 5p and 5q not on the same chromosome 
(E); two copies of TERT are present (F). Representative example of an individual 
with an interstitial deletion with only one copy of 5p but two copies of the 
TERT is shown in (G, H).Telomere length in 5p– syndrome, H.-Y. Du et al.
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deletion, whose telomere lengths are far below the 5th percen-
tile (see Fig. 3A,B), telomere lengths in blood cells from individ-
uals with 5p– syndrome and a TERT gene deletion were only
marginally shorter than normal controls (see Fig. 3A,B). We have
also quantitatively estimated the differences in the rate of
telomere shortening. It was found that telomere lengths were
shortened by 1.1 relative fluorescence units (RFU) in the first
generation of individuals with 5p– syndrome compared to
normal controls (P = 0.0147). In contrast, in the autosomal
dominant DC patients with a TERC gene deletion telomere
lengths were on average 5.6 RFU lower than in individuals with
5p– syndrome (P < 0.0001).
Normal peripheral blood cell counts but a decreased 
number of circulating hematopoietic progenitor cells 
in individuals with 5p– syndrome
The majority of individuals with DC develop signs of bone
marrow failure (Marrone et al., 2005; Mason et al., 2005), which
is thought to be due to a deficiency of telomerase in hemat-
opoietic stem cells and their immediate progeny. We therefore
wanted to know whether a TERT gene deletion in individuals
with 5p– syndrome was associated with impaired hematopoiesis.
Bone marrow biopsy was deemed inappropriate on ethical
grounds, so we used peripheral blood as a surrogate to evaluate
the effect of the TERT gene deletion on hematopoiesis (see
Fig. 4). With the exception of four individuals who had slightly
decreased hemoglobin levels (11–13 g dL
–1 respectively), peripheral
blood values were normal for hemoglobin (13.07 ± 1.28 g dL
–1),
white blood cell counts (8.33 ± 2.7 × 10
3 per µL), platelet count
(277.44 ± 72.82 × 10
3 per µL), mean corpuscle volume (87.23
± 5.05 fl), and polymorphonuclear cells count (4.07 ± 1.59 ×
10
3 per µL).
As an additional parameter we also analyzed the number of
circulating hematopoietic progenitor cells in this study, using a
clonogenic progenitor assay. Surprisingly, the number of colon-
ies formed in individuals with 5p– syndrome was significantly
less than in unaffected family members (Fig. 5A; median 21.5
vs. 56.5; P = 0.0012). Among the three colony types identified,
burst-forming units–erythroid (BFU-E) and colony forming units–
granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM)
showed a significant decrease in individuals with 5p– syndrome
(Fig. 5B; P = 0.001 and 0.033, respectively), whereas the reduction
in colony-forming unit–granulocyte, macrophage (CFU-GM)
Fig. 3 Telomere lengths in individuals with 5p– syndrome and normal study 
controls. (A) Telomere length of peripheral blood mononuclear (PBMN) cells 
from individuals with 5p– syndrome ( , n = 44), family members (×, n = 69), 
and dyskeratosis congenita patients carrying a TERC-3′ deletion ( , n = 9) 
were measured by flow cytometry fluorescence in situ hybridization (FISH). 
The lines represent the 90th, 75th, 50th, 25th, 10th and 5th percentile of 
the telomere length in healthy controls (n = 105). The three 5p– individuals 
with two copies of TERT are labeled ( ). Telomere length was expressed as 
the mean fluorescence of PBMN relative to a tetraploid cell line. (B) Telomere 
length in peripheral blood cells from individuals with 5p– syndrome and family 
members (parents and siblings) determined by in-gel hybridization. The first 
number indicates the family number; the second number indicates the family 
relation to the proband. Individuals with 5p– syndrome are shown in bold 
and were assigned. .1, .2 represents the mother; .3 the father; and .4 the 
sibling within one family. The age of each individual is shown. Lanes 16 and 
17 show the telomere length of a DC patient with a TERC gene deletion, 
and one of his unaffected family members without the deletion. Note the 
very short telomeres in the DC patient with a TERC deletion (Lane 16) as 
compared to the telomere lengths seen in 5p– individuals.
Fig. 4 Blood values from individuals with 5p– syndrome. Blood values 
obtained from 40 individuals with 5p– syndrome are shown. Each box plot 
represents the minimum, the 25% percentile, the median, the 75% percentile 
and the maximum of blood values. Median values are indicated. WBC, white 
blood cell counts; Hgb, hemoglobin; PMN, polymorphonuclear cells; PLT, 
platelets; MCV, mean corpuscular volume of red cells. Boxes with broken line 
represent normal range.Telomere length in 5p– syndrome, H.-Y. Du et al.
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did not reach statistical significance when compared to family
members (P = 0.06). The size of the colonies formed by pro-
genitors from individuals with 5p– syndrome were similar to
those formed by normal controls as demonstrated by a propor-
tional decrease of cell numbers harvested from the respective
culture plates (Fig. 4C; P = 0.004). There was no significant cor-
relation between telomere length and the number of circulating
progenitor cells (r = 0.306, P = 0.094).
Discussion
There is an ongoing debate about the extent to which TERT and
TERC are limiting for telomere length (Liu et al., 2000; Chiang
et al., 2004; Hao et al., 2005a). Here we investigated the effect
of a TERT gene deletion on telomere lengths in individuals
with 5p– syndrome. Our studies showed that telomere lengths
in individuals with 5p– syndrome, who are haploinsufficient for
the TERT gene, are only slightly shorter than telomere lengths
in normal controls, who have two copies of TERT. Shorter telo-
meres were previously demonstrated by Zhang and colleagues
in eight individuals with 5p– syndrome compared to eight
normal controls, with the conclusion that significant telomere
shortening was evident in 5p– and might contribute to the 5p–
phenotype (2003). However, the study did not take into account
the wide distribution of telomere lengths in the normal popu-
lation and lacks sufficient numbers of normal controls and 5p–
individuals to evaluate the extent of telomere shortening in
these individuals. In our study, telomere lengths of 44 individ-
uals with 5p– syndrome were compared with a much larger
group of control individuals (n = 105). Both populations showed
a wide distribution of telomere lengths, which were largely over-
lapping. These results, in contrast to the previous study, put the
telomere shortening observed in individuals with 5p– into pro-
portion, indicating that telomere shortening in individuals with
5p– syndrome, although significant, is minimal and that the
majority of telomere lengths of individuals with 5p– syndrome
still fall within the distribution of normal telomere lengths (5th–
95th percentile, see Fig. 3A). Comparing telomere lengths of
individuals with 5p– syndrome to the telomere lengths in
individuals with autosomal dominant DC due to a TERC gene
deletion, we find that individuals with 5p– have much longer
telomeres than individuals with autosomal dominant DC and a
TERC gene deletion, both by flow cytometry FISH and by South-
ern blotting (see Fig. 3A,B).
The most likely explanation for these findings is that in indi-
viduals with 5p– syndrome, haploinsufficiency for TERT almost
always occurs de novo (Mainardi et al., 2006) and, as demon-
strated here, within one generation this does not lead to the
excessively short telomeres seen in individuals with autosomal
dominant DC due to an inherited TERC gene deletion. These
findings strongly support the hypothesis of anticipation and
underline the importance of anticipation in the pathogenesis of
disease in patients with autosomal dominant DC.
Anticipation due to the inheritance of increasingly shorter telo-
meres is a unique characteristic of autosomal dominant DC.
It explains the increasing severity and younger age of onset of
the disease in later generations in patients with autosomal dom-
inant DC (Vulliamy et al., 2001, 2004; Mason, 2003; Armanios
et al., 2005; Goldman et al., 2005). The cumulative effect of
telomere shortening over several generations also explains why
even a minimal impairment of telomerase activity will eventually
lead to telomeres sufficiently short to cause disease.
An alternative explanation of our finding could be that hap-
loinsufficiency for TERC has a different effect on telomere length
from haploinsufficiency for TERT. In mice, TERT and Terc RNA
deficiency showed a very similar rate of telomere shortening
and an almost identical phenotype after several generations
of inbreeding (Blasco et al., 1997; Liu et al., 2000). However,
Fig. 5 Circulating progenitor cells in individuals with 5p– syndrome and study controls. Each box plot represents the minimum, the 25% percentile, the median, 
the 75% percentile and the maximum. Median values are indicated. (A) The number of colony forming units (CFU) formed from peripheral blood was less in 
5p– individuals compared to family members (n = 17, P = 0.0012). (B) Among the three types of colonies identified: burst forming unit-erythroid (BFU-E), colony 
forming unit–granulocyte, macrophage (CFU-GM), and CFU–granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GMMM), a significant decrease in 5p– 
individuals was found in BFU-Es (P = 0.001) and CFU-GEMMs (P = 0.033). (C) Total number of cells in cell culture is significantly decreased in 5p– individuals 
compared to family members (P = 0.004).Telomere length in 5p– syndrome, H.-Y. Du et al.
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telomere dynamics differ in mouse and humans. In contrast to
humans, mice Terc RNA or Tert haploinsufficiency is not asso-
ciated with the development of a disease phenotype (Blasco
et al., 1997; Liu et al., 2000; Chiang et al., 2004; Hathcock et al.,
2005), whereas in humans homozygosity or compound heter-
ozygosity for telomerase null mutations have never been described
and are most likely not compatible with life. We can not exclude
that TERC and TERT haploinsufficiency might have a different
effect on telomere lengths in humans. Samples from patients
with autosomal dominant DC due to a TERT gene mutation
were not available to us; but the fact that autosomal dominant
DC occurs in families with inherited TERC or TERT gene muta-
tions strongly supports our hypothesis that in the majority of
humans neither haploinsufficiency for TERT nor for TERC leads
to excessively short telomeres or autosomal dominant DC dis-
ease in the first generation.
We expected that telomere shortening due to TERT haplo-
insufficiency would be most significant during embryonic devel-
opment, but we were surprised to find that telomere lengths in
children with 5p– syndrome below the age of 5 years were not
significantly different to normal controls (see Fig. 3), but telo-
mere loss appeared to be accelerated thereafter. This raises
the interesting question of when in human life telomerase hap-
loinsufficiency affects telomere length the most. Interestingly,
individuals with autosomal dominant DC due to TERC gene
deletions have very short telomeres already at a very young age
(see Fig. 3A). We hypothesize that there is a lower limit of
telomere length for a functional blood cell and that lower limit
is reached in autosomal dominant DC patients with disease
(Goldman et al., 2005). Blood progenitor cells with shorter
telomeres stop dividing or die leading to the bone marrow failure
in individuals with autosomal dominant DC.
Interestingly, some individuals with 5p– showed ridged fin-
gernails and early graying of their hair, a clinical manifestation
associated with premature aging. Similarly, individuals with
5p– syndrome had low numbers of circulating peripheral blood
progenitor cells compared to normal controls, which is suggestive
for bone marrow failure. However, fingernail changes were also
found in one of the three individuals with 5p– syndrome having
two copies of the TERT gene, and equally low numbers of
circulating blood progenitor cells were present in all three 5p–
individuals with two copies of TERT. Early graying of hair was
not seen in individuals with 5p– syndrome and with two copies
of TERT, but all three were below the age of 10. Although we
cannot formally exclude that some of these features are caused
by short telomeres in the specific tissue, the fact that some of
these features were found also in individuals with 5p– but two
copies of TERT suggests that the observed changes of the nails,
early hair graying, and the decreased number of circulating
hematopoietic progenitor cells are due to haploinsufficiency of
one or more of the other genes involved in the large chromo-
somal deletion. Similarly, although none of the affected genes
other than TERT is involved in telomere maintenance, we cannot
exclude that their haploinsufficiency directly or indirectly influ-
ences telomere length.
In summary, our data demonstrate accelerated telomere
shortening in individuals with 5p– syndrome. The residual telo-
mere length, rather than reduced telomerase activity, has been
implicated to be responsible for the phenotype in telomerase
deficient mice (Hao et al., 2005b). Short telomeres have also been
implicated in the pathology of patients with DC. Our analysis
demonstrates that within one generation, telomeres do not
become sufficiently short to cause disease or contribute to the
5p– phenotype. However, whether TERT haploinsuffciency con-
tributes to the 5p– phenotype outside of its role on telomeres
remains to be determined (Blackburn, 2005).
Experimental procedures
Human subjects
The study group comprised 52 individuals with 5p– syndrome
from 51 families: 37 individuals (36 families) were enrolled
during the annual meeting of the 5p– Society held in St. Louis,
MO, USA, in July 2005, and 15 individuals (15 families) were
enrolled during the annual meeting held in Santa Clara, CA,
USA, in 2006. Seventy-nine family members (parents and siblings)
were included as ‘intrastudy controls’. All individuals with 5p–
syndrome had been previously diagnosed by cytogenetic ana-
lysis in clinically approved laboratories. The diagnosis of 5p–
syndrome was confirmed by review of medical records. In selected
cases the diagnosis was additionally confirmed by FISH using
the commercially available LSI D5S23, D5S721/5q31 LSI EGR1
probe (Vysis XY, Downers Grove, IL, USA; see also below). After
informed consent was obtained, individuals were examined
with a particular emphasis on the presence of classical features
associated with DC (abnormal skin pigmentation, dystrophic
fingernails, leukoplakia and early graying of the hair), and blood
was drawn from a peripheral vein. Forty-five blood samples
were collected from the participants with 5p– syndrome and
79 from the study controls. Blood samples were analyzed within
36 h. Approval for the study was obtained by the Washington
University School of Medicine Institutional Review Board.
Q-PCR for detection of a TERT gene deletion
Genomic DNA was extracted from peripheral blood leukocytes
with the DNA blood mini kit (Qiagen, Valencia, CA, USA). Aliquots
of 20 ng DNA were assayed with a SYBR Green core reagent kit
(Applied Biosystems, Foster City, CA, USA). The primer sequences
for the TERT gene were: F: 5’-ACGAGCACCGTCTGATTAGG-3’;
R: 5’-GGGTTCTTCCAAACTTGCTG-3’. β-globin gene served as
the reference gene in the determination of the copy number
of TERT (Cawthon, 2002). All PCRs were performed on the Prism
7000 Sequence Detection System (Applied Biosystems) follow-
ing the instructions of the manufacturer. Serial dilutions (5–
80 ng) of reference DNA (a pool of DNA samples) were used
to plot the standard curve for the TERT gene and reference gene
β-G. The 2
–∆∆C
T method was adopted to analyze the data (Livak
& Schmittgen, 2001). Individual copy number of TERT  wasTelomere length in 5p– syndrome, H.-Y. Du et al.
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expressed as the ratio of TERT/β-G of each sample relative
to the average ratio of individuals with 5p– syndrome.
Telomere length measurement by flow cytometric FISH
Telomere length of peripheral blood mononuclear (PBMN) cells
isolated by Ficoll–Hypaque gradient centrifugation was measured
as previously described (Goldman et al., 2005) using fluorescin
(FITC)-conjugated (C3TA2)3 peptide nucleic acid (PNA, Applied
Biosystems) probe with a flow cytometer (Beckman Coulter,
Fullerton, CA, USA). Relative telomere length was determined
by comparing isolated PBMC with a control cell line (GM03671C;
Coriell Institute of Medical Research, Camden, NJ, USA), a tetra-
ploid cell line, which served as an internal control and was
assigned a telomere length of 100%. Telomere lengths of 105
healthy individuals (ranging from 3 to 94 years old) were used
to determine the distribution of age-dependent telomere length.
Terminal restriction fragment length analysis by 
in-gel hybridization
The average telomere restriction fragment length of genomic
DNA was determined as previously described (Goldman et al.,
2005). Briefly, 3 µg of genomic DNA digested with restriction
enzymes RsaI and HinfI (Invitrogen, Carlsbad, CA, USA) were
electrophoresed on a 0.5%/0.6 × TBE agarose gel along with
Lambda HindIII marker. After gel drying, denaturing and neu-
tralization, gels were hybridized to a γ
32P-end-labeled telomeric
probe. The average telomere restriction fragment length was
determined using the Imagequant™ software.
FISH analyses
The diagnosis of 5p– syndrome and the deletion of the TERT
gene were confirmed by FISH analysis of metaphase chromo-
somes prepared from fresh PBMC or Epstein-Barr virus-
transformed B lymphocytes as previously described with minor
modifications (Goldman et al., 2005). Metaphase spreads were
subjected to the hybridization procedure using a Biotin-labeled
TERT probe synthesized from a previously isolated and entirely
sequenced BAC spanning the whole TERT locus (Leem et al.,
2002), by a nick translation kit (Vysis). The slides were then incu-
bated with avidin-Texas red (Vector laboratories, Burlingame,
CA, USA) followed by antiavidin antibody (Vector laboratories)
to amplify the signal. After double staining with a commercially
available LSI D5S23, D5S721/5q31 LSI EGR1 probe (Vysis), the
metaphase spreads were counterstained with 4′,6-diamidino-
2-phenylindole (DAPI) and visualized under a fluorescence
microscope (Nikon, Melville, NY, USA).
Measurement of telomerase activity in CD3/CD28-
stimulated peripheral blood T cells
PBMN cells (10
6) were mixed with 25 µL Dynabeads CD3/
CD28 T cell expander (Invitrogen) and further stimulated
with 50 U mL
–1 rIL-2 (Pharmingen, Franklin Lakes, NJ, USA). The
stimulated cells were removed from the beads using a
magnet (Invitrogen) and stored at –80 °C until use. Protein was
extracted from stimulated cells by CHAPS XL lysis buffer (Chemi-
con, Temecula, CA, USA) and quantified using the RC DC Pro-
tein assay kit (Bio-Rad, Hercules, CA, USA). Telomerase activity
was measured by a Q-PCR based telomeric repeat amplification
protocol (TRAP) assay (Kim & Wu, 1997; Uehara, 2006) with
minor modifications. Thermal cycling reactions were per-
formed with the Prism 7000 Sequence Detection System
(Applied Biosystems).
TERT mRNA levels in CD3/CD28-stimulated T cells from 
peripheral blood
RNA was extracted from CD3/CD28-stimulated T cells by the
RNeasy mini kit (Qiagen). cDNA was synthesized from 2 µg RNA
using Superscript III RT (Invitrogen). cDNA samples were sub-
jected to Q-PCR using a SYBR Green core reagent kit (Applied
Biosystems) along with the primers: TERT-F: 5’-GCCGATTGT-
GAACATGGAC; TERT-R: GCTGAACAGTGCCTTCACC. In par-
allel, each sample was run with primers: G3PDH-F: 5’-GAAGGT-
GAAGGTCGGAGTC; G3PDH-R; 5’-GAAGATGGTGATGGGATTTC
as internal control. The amount of TERT mRNA was quantified
by the 2
–∆∆C
T method as described above.
Progenitor assay
PBMN cells (2 × 10
5) were plated in duplicates in 1 mL methyl-
cellulose medium (MethoCult GF H4434, Stem Cells Techno-
logies, Tukwila, WA, USA) and incubated at 37 °C. Colonies
were scored and counted after 10 days of culture. The cells were
subsequently collected and counted using a Coulter counter
(Beckman Coulter).
Statistical analysis
All analyses were performed using the SAS computer software
(version 9.1, SAS Institute, Cary, NC, USA). Generalized linear
model (SAS GLM procedure) was used to assess whether
TERT deletion was a significant predictor of telomere length,
adjusted for the effects of age, gender and race. The telomere
lengths among groups (subjects with 5p– syndrome, un-
affected family controls and DC patients carrying one copy
deletion of TERC) were compared by using Duncan’s and Tukey’s
tests. Furthermore, nonindependence of family members was
adjusted by using the robust covariance matrix estimator,
which asymptotically yielded the same parameter estimates,
but the standard errors and associated test were corrected
for the dependence. The method assumed same degree of
dependency among all members of each family. The Kruskal–
Wallis nonparametric test followed by Dunnett C test was used
for the comparison of CFU between 5p– individuals and family
controls. In this report, P < 0.05 was considered statistically
significant.Telomere length in 5p– syndrome, H.-Y. Du et al.
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